Literature DB >> 25598583

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

Ke Huang1, Zachary S Breitbach1, Daniel W Armstrong1.   

Abstract

The enantiomeric excess of chiral reagents used in asymmetric syntheses directly affects the reaction selectivity and product purity. In this work, 84 of the more recently available chiral compounds were evaluated to determine their actual enantiomeric composition. These compounds are widely used in asymmetric syntheses as chiral synthons, catalysts, and auxiliaries. These include chiral alcohols, amines, amino alcohols, amides, carboxylic acids, epoxides, esters, ketones, and oxolanes among other classes of compounds. All enantiomeric test results were categorized within five purity levels (i.e. <0.01%, 0.01% to 0.1%, 0.1% to 1%, 1% to 10%, and >10%). The majority of the reagents tested were determined to have enantiomeric impurities over 0.01%, and two of them were found to contain enantiomeric impurities exceeding the 10% level. The most effective enantioselective analysis method was a GC approach using a Chiraldex GTA chiral stationary phase (CSP). This method worked exceedingly well with chiral amines and alcohols.

Entities:  

Year:  2006        PMID: 25598583      PMCID: PMC4294700          DOI: 10.1016/j.tetasy.2006.10.014

Source DB:  PubMed          Journal:  Tetrahedron Asymmetry        ISSN: 0957-4166


  51 in total

1.  Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.

Authors:  J Jiang; A H Li; S Y Jang; L Chang; N Melman; S Moro; X Ji; E B Lobkovsky; J C Clardy; K A Jacobson
Journal:  J Med Chem       Date:  1999-08-12       Impact factor: 7.446

2.  Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.

Authors:  Ronald Palin; David R Barn; John K Clark; Jean E Cottney; Phillip M Cowley; Marc Crockatt; Louise Evans; Helen Feilden; Richard R Goodwin; Frank Griekspoor; Simon J A Grove; Andrea K Houghton; Philip S Jones; Richard J Morphy; Alasdair R C Smith; Hardy Sundaram; David Vrolijk; Mark A Weston; Grant Wishart; Paul Wren
Journal:  Bioorg Med Chem Lett       Date:  2005-02-01       Impact factor: 2.823

3.  Structure-affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5HT3 receptor.

Authors:  Andrea Cappelli; Germano Giuliani; Andrea Gallelli; Salvatore Valenti; Maurizio Anzini; Laura Mennuni; Francesco Makovec; Aroldo Cupello; Salvatore Vomero
Journal:  Bioorg Med Chem       Date:  2005-05-16       Impact factor: 3.641

4.  Piperazine additions to C60--a facile approach to fullerene substitution.

Authors:  Craig P Butts; Mikael D S Jazdzyk
Journal:  Org Biomol Chem       Date:  2005-02-22       Impact factor: 3.876

5.  Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 1.

Authors:  Kyoji Tomita; Yasunori Tsuzuki; Koh-ichiro Shibamori; Masanori Tashima; Fumie Kajikawa; Yuji Sato; Shigeki Kashimoto; Katsumi Chiba; Katsuhiko Hino
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

6.  Diastereoselective ring-closing metathesis: synthesis of P-stereogenic phosphinates from prochiral phosphinic acid derivatives.

Authors:  Katherine S Dunne; Fabrice Bisaro; Barbara Odell; Jean-Marc Paris; Véronique Gouverneur
Journal:  J Org Chem       Date:  2005-12-23       Impact factor: 4.354

7.  Asymmetric Addition of Alkyllithium to Chiral Imines: alpha-Naphthylethyl Group as a Chiral Auxiliary.

Authors:  Hideki Yamada; Tomohiko Kawate; Atsushi Nishida; Masako Nakagawa
Journal:  J Org Chem       Date:  1999-11-26       Impact factor: 4.354

8.  An experimentally derived model for stereoselectivity in the aerobic oxidative kinetic resolution of secondary alcohols by (sparteine)PdCl2.

Authors:  Raissa M Trend; Brian M Stoltz
Journal:  J Am Chem Soc       Date:  2004-04-14       Impact factor: 15.419

9.  Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.

Authors:  K Shankaran; Karla L Donnelly; Shrenik K Shah; Ravindra N Guthikonda; Malcolm MacCoss; John L Humes; Stephen G Pacholok; Stephan K Grant; T M Kelly; K K Wong
Journal:  Bioorg Med Chem Lett       Date:  2004-09-06       Impact factor: 2.823

10.  Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.

Authors:  Yasunori Tsuzuki; Kyoji Tomita; Koh-ichiro Shibamori; Yuji Sato; Shigeki Kashimoto; Katsumi Chiba
Journal:  J Med Chem       Date:  2004-04-08       Impact factor: 7.446

View more
  2 in total

1.  Enantiomeric separation of biaryl atropisomers using cyclofructan based chiral stationary phases.

Authors:  Ross M Woods; Darshan C Patel; Yeeun Lim; Zachary S Breitbach; Hongyin Gao; Craig Keene; Gongqiang Li; László Kürti; Daniel W Armstrong
Journal:  J Chromatogr A       Date:  2014-05-02       Impact factor: 4.759

Review 2.  Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.

Authors:  Morgan E Rook; Amber L Southwell
Journal:  BioDrugs       Date:  2022-03-07       Impact factor: 7.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.